Evaluation of External Application of Varnyakar Lepa and Leech therapy in Vyanga(Melasma)

To evaluate the role of Jalukavacharan with Varnyakar lepa in management of Vyanga(Melasma) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062768

Enrollment

Registered

2024-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with signs & symptoms of Vyanga. 2 Signs & symptoms of Melasma.

Exclusion criteria

Exclusion criteria: 1 Known case of any active skin malignancy 2 Pregnant woman 3 Patients suffering from all major systemic diseases IHD HIV Carcinoma 4 Patients having contagious infectious disease such as active tuberculosis Hepatitis B and C 5 Cases of burn & any skin allergy 6 Any lesion of other skin disease

Design outcomes

Primary

Measure	Time frame
Evaluate effect of Jalaukawacharan & Varnykar lepa in Vyanga (melasma) on the basis if assessment criteria of colour of melasma size of lesion & MASI score.Timepoint: Follow up- 1st,15th, 30th ,45 th ,60 th day	—

Secondary

Measure	Time frame
To observe the recurrence of melasmaTimepoint: After leech application- 30th,45th, 60th day	—

Countries

India

Contacts

Public ContactDr Pratiksha Dundappa Talawar

Dr.J.J.Magdum Ayurved Medical College Jaysingpur

dr.pratiksha2009@gmail.com8975166148

Outcome results